Balyasny Asset Management
Tracked across 3 events · 19 articles · First seen Apr 06, 2026 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Balyasny Asset Management is one of the new investors participating in the $350 million private placement financing for the combined Galera Therapeutics and Obsidian Therapeutics, Inc. entity.
Apr 14, 2026 · 7 articles
Business
Werewolf Therapeutics and Ambros Therapeutics announced a definitive all-stock merger agreement to create a combined company focused on advancing neridronate, Ambros' late-stage treatment for Complex Regional Pain Syndrome Type 1 (CRPS-1). The combined company will…
Impact: Balyasny Asset Management participated in the private placement, contributing to the financing round.
Aug 21, 2026 · 6 articles
Business
Impact: Balyasny Asset Management L.P. lifted its position in shares of AirSculpt Technologies during the second quarter.
Apr 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Balyasny Asset Management live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard